Active Ingredient

Dr Reddy's saw API revenues slide in FY Q1 2018

Dr Reddy's saw API revenues slide in FY Q1 2018

By Gareth Macdonald

Dr Reddy's says efforts to fix plant problems flagged by US FDA impacted its active pharmaceutical ingredient (API) business in the first quarter of fiscal 2018.

iStock/macgyverhh

PE firms' plan to take AMRI private on track

By Staff reporter

The Carlyle Group and GTCR LLC are poised to complete the takeover of Albany Molecular Research (AMRI) after the early termination of the mandatory waiting period that covers such deals in the US.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers